Ruirui Wang

446 total citations
6 papers, 351 citations indexed

About

Ruirui Wang is a scholar working on Molecular Biology, Pharmacology and Cancer Research. According to data from OpenAlex, Ruirui Wang has authored 6 papers receiving a total of 351 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Molecular Biology, 4 papers in Pharmacology and 2 papers in Cancer Research. Recurrent topics in Ruirui Wang's work include Hops Chemistry and Applications (2 papers), Cancer-related molecular mechanisms research (2 papers) and MicroRNA in disease regulation (2 papers). Ruirui Wang is often cited by papers focused on Hops Chemistry and Applications (2 papers), Cancer-related molecular mechanisms research (2 papers) and MicroRNA in disease regulation (2 papers). Ruirui Wang collaborates with scholars based in China and United States. Ruirui Wang's co-authors include Zixuan Wang, JS Yang, Xuan Pan, Wei De, Hanyu Wang, Xinfang Yu, Ying Ma, Jun Zhou, Pengfei Guo and Qiang Wang and has published in prestigious journals such as Oncogene, British Journal of Cancer and The American Journal of Chinese Medicine.

In The Last Decade

Ruirui Wang

5 papers receiving 343 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ruirui Wang China 4 309 278 30 30 19 6 351
Yao‐Jie Pan China 10 255 0.8× 190 0.7× 36 1.2× 21 0.7× 22 1.2× 17 319
Evan J. Greenawalt United States 5 234 0.8× 193 0.7× 46 1.5× 21 0.7× 25 1.3× 5 277
Jiali Long China 8 306 1.0× 262 0.9× 34 1.1× 22 0.7× 25 1.3× 12 371
Pooja Joshi United States 5 251 0.8× 230 0.8× 29 1.0× 30 1.0× 14 0.7× 6 301
Stephen Wahlig United States 5 207 0.7× 194 0.7× 49 1.6× 21 0.7× 16 0.8× 7 349
Brian McCue United States 5 389 1.3× 340 1.2× 37 1.2× 18 0.6× 25 1.3× 8 472
Guihong Zhang China 8 268 0.9× 238 0.9× 39 1.3× 12 0.4× 30 1.6× 13 347
Claudia Stellato Italy 9 197 0.6× 116 0.4× 46 1.5× 30 1.0× 15 0.8× 10 281
Yaozhou He China 10 403 1.3× 347 1.2× 35 1.2× 24 0.8× 51 2.7× 14 441
Fangyong Lei China 9 285 0.9× 238 0.9× 49 1.6× 22 0.7× 35 1.8× 10 354

Countries citing papers authored by Ruirui Wang

Since Specialization
Citations

This map shows the geographic impact of Ruirui Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ruirui Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ruirui Wang more than expected).

Fields of papers citing papers by Ruirui Wang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ruirui Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ruirui Wang. The network helps show where Ruirui Wang may publish in the future.

Co-authorship network of co-authors of Ruirui Wang

This figure shows the co-authorship network connecting the top 25 collaborators of Ruirui Wang. A scholar is included among the top collaborators of Ruirui Wang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ruirui Wang. Ruirui Wang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

6 of 6 papers shown
1.
Liu, Wen, et al.. (2025). Targeting EGFR-Mcl-1 Axis by Piperlongumine as a Novel Strategy for Non-Small Cell Lung Cancer Therapy. The American Journal of Chinese Medicine. 53(2). 597–619.
2.
Ma, Ying, et al.. (2024). Xanthohumol overcomes osimertinib resistance via governing ubiquitination-modulated Ets-1 turnover. Cell Death Discovery. 10(1). 454–454. 3 indexed citations
3.
Wang, Ruirui, et al.. (2024). Xanthohumol Promotes Skp2 Ubiquitination Leading to the Inhibition of Glycolysis and Tumorigenesis in Ovarian Cancer. The American Journal of Chinese Medicine. 52(3). 865–884. 5 indexed citations
4.
Han, Shuangze, et al.. (2023). Isoliquiritigenin Inhibits Oral Squamous Cell Carcinoma and Overcomes Chemoresistance by Destruction of Survivin. The American Journal of Chinese Medicine. 51(8). 2221–2241. 7 indexed citations
5.
6.
Wang, Ruirui, et al.. (2011). MicroRNA-451 functions as a tumor suppressor in human non-small cell lung cancer by targeting ras-related protein 14 (RAB14). Oncogene. 30(23). 2644–2658. 257 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Yao‐Jie Pan Breakdown of academic impact, for papers by Evan J. Greenawalt Breakdown of academic impact, for papers by Jiali Long Breakdown of academic impact, for papers by Pooja Joshi Breakdown of academic impact, for papers by Stephen Wahlig Breakdown of academic impact, for papers by Brian McCue Breakdown of academic impact, for papers by Guihong Zhang Breakdown of academic impact, for papers by Claudia Stellato Breakdown of academic impact, for papers by Yaozhou He Breakdown of academic impact, for papers by Fangyong Lei
Rankless by CCL
2026